TENX - TENAX THERAPEUTICS, INC.

14.51
3.490   24.052%

Share volume: 2,124,757
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.17%

PREVIOUS CLOSE
CHG
CHG%
$11.02
3.49
0.32%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
22%
Profitability 25%
Dept financing 6%
Liquidity 50%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
35.73%
1 Month
11.62%
3 Months
47.31%
6 Months
136.32%
1 Year
134.41%
2 Year
261.85%
Key data
Stock price
$14.51
P/E Ratio 
N/A
DAY RANGE
$12.00 - $14.60
EPS 
-$2.78
52 WEEK RANGE
$4.63 - $18.38
52 WEEK CHANGE
$126.72
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
6.244 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
0.48
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$511,419
AVERAGE 30 VOLUME 
$299,130
Company detail
CEO: Christopher T. Giordano
Region: US
Website: tenaxthera.com
Employees: 9
IPO year: 1997
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Tenax Therapeutics, Inc. engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. The company was founded in 1967 and is headquartered in Morrisville, North Carolina.

Recent news